Plus Therapeutics (PSTV) Misses Q3 EPS by 4c

Plus Therapeutics (NASDAQ: PSTV) reported Q3 EPS of ($0.04). Revenue for the quarter came in at $1.4 million.

For earnings history and earnings-related data on Plus Therapeutics (PSTV) click here.

You May Also Be Interested In

• Elon Musk’s trillion-dollar meltdown: How SpaceX and Tesla erased $700 billion
• 1win Breaks World Record by Bringing Football to the Top of Bogotá
• TPU-As-A-Service could boost Google’s 2028 profit by over 15%: Barclays